Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
76.00    -8.50 (-10.06%)
Bid:
75.00
Ask:
77.00
Spread: 2.00 (2.667%)
Market Cap: £11.03m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Director/PDMR Shareholding

19 Sep 2017 10:16

RNS Number : 1584R
Ingenta PLC
19 September 2017
 

19 September 2017

Ingenta plc

Directors' Dealings

Ingenta plc (LSE:ING, "Company" or "Ingenta") received notification on 18 September 2017 from Kestrel Partners LLP ("Kestrel") that on 18 September 2017 it acquired, on behalf of its discretionary clients, 20,000 ordinary shares of 10p each ("Shares") in the Company at a price of £1.52 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr. Royde is a partner of, and holds a beneficial interest in Kestrel. Mr. Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ingenta.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 4,494,254 Shares in the Company.

Of the Shares purchased, 17,000 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr. Royde is deemed to have a beneficial interest in) 3,415,733 Shares in the Company. The remaining 3,000 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Royde has no beneficial interest, who, following this transaction, hold a further 1,098,521 Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 4,514,254 Shares in the Company, which represents approximately 26.68% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

3,415,733

20.19%

Indirect

JIM Nominees Limited

281,531

1.66%

Indirect

Bank of New York Nominees Ltd

816,990

4.83%

 

 

For further information contact:

Ingenta PlcDavid Montgomery

 

+44 (0) 1865 397 800

Cenkos Securities plcNicholas Wells

Elizabeth Bowman

 

 

+44 (0) 20 7397 8900

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Matthew Max Edward Royde (Non-Executive Director, Ingenta plc)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Ingenta plc

b)

 

LEI

 

 

213800QU4IVLTQZL3T37

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

10p Ordinary Shares

 

 

ISIN: GB00B3BDTG73

 

b)

 

Nature of the transaction

 

 

Purchase

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

GBP 1.52

 

20,000 Shares

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Total 20,000 shares @ GBP 1.52

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2017-09-18

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGMLLLDGNZG
Date   Source Headline
25th Jun 20267:00 amRNSAGM Trading Update
1st May 20267:01 amRNS-RInvestor Presentation via Investor Meet Company
1st May 20267:00 amRNSPosting of Annual Report & Notice of AGM
27th Apr 20267:00 amRNSFinal Results
22nd Jan 20267:00 amRNSTrading Update
18th Nov 20254:30 pmRNSHolding(s) in Company
18th Nov 20254:29 pmRNSHolding(s) in Company
4th Nov 20253:21 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20255:27 pmRNSHolding(s) in Company
18th Sep 202511:00 amRNSInvestor Presentation via Investor Meet Company
15th Sep 20257:00 amRNSHalf-year Report
26th Jun 20254:42 pmRNSResult of Annual General Meeting
7th May 20254:54 pmRNSPosting of Annual Report & Notice of AGM
28th Apr 20257:00 amRNSFinal Results
7th Feb 20257:00 amRNSTrading Update
15th Nov 20244:52 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSHalf-year Report
18th Jul 20244:42 pmRNSResult of AGM and Directorate Change
3rd Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20244:30 pmRNSPosting of Annual Report & Notice of AGM
3rd Jun 20247:00 amRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSInvestor Presentation via Investor Meet Company
28th May 20247:00 amRNSFinal Results
17th May 20242:20 pmRNSFinal Results Update
31st Jan 20247:00 amRNSTrading Update
25th Oct 20233:57 pmRNSChange of Nomad and Broker
17th Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSNew customer wins
11th Sep 20237:00 amRNSHalf-year Report
8th Sep 20232:44 pmRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Update
29th Jun 202312:52 pmRNSResult of AGM & Dividend Timetable
29th Jun 20237:00 amRNSAGM statement and contract wins
25th May 20234:00 pmRNSPosting of Annual Report & Notice of AGM
17th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20237:00 amRNSFinal Results
28th Apr 20237:00 amRNSNotice of Final Results
2nd Feb 20237:00 amRNSTrading Update
2nd Dec 20226:02 pmRNSDirector/PDMR Shareholding
16th Nov 20224:31 pmRNSHolding(s) in Company
14th Nov 20223:57 pmRNSResult of Tender Offer
11th Nov 202211:24 amRNSResult of General Meeting
25th Oct 20227:00 amRNSProposed Tender Offer & Notice of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20222:09 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSTrading Update
28th Jul 20223:02 pmRNSResult of AGM and Dividend Timetable
8th Jul 20227:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.